Clioquinol rescues yeast cells from Aβ42 toxicity via the inhibition of oxidative damage
Biotechnology Journal · 2024
DOI: 10.1002/biot.202300662 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, 2024. Verfasst von Qiaoqiao Zheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China. Hauptthemen laut MEDLINE: Oxidative Stress, Amyloid beta-Peptides, Saccharomyces cerevisiae, Clioquinol. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Shanghai Natural Science Foundation, The Open Project of Qinghai Key Laboratory of Qinghai-Tibet Plateau Biological Resources, Natural Science Foundation of Shanghai Municipality.
Abstract (Originalsprache)
Alzheimer's disease (AD), the most common form of dementia, has gotten considerable attention. Previous studies have demonstrated that clioquinol (CQ) as a metal chelator is a potential drug for the treatment of AD. However, the mode of action of CQ in AD is still unclear. In our study, the antioxidant effects of CQ on yeast cells expressing Aβ42 were investigated. We found that CQ could reduce Aβ42 toxicity by alleviating reactive oxygen species (ROS) generation and lipid peroxidation level in yeast cells. These alterations were mainly attributable to the increased reduced glutathione (GSH) content and independent of activities of superoxide dismutase (SOD) and/or catalase (CAT). CQ could affect antioxidant enzyme activity by altering the transcription level of related genes. Interestingly, it was noted for the first time that CQ could combine with antioxidant enzymes to reduce their enzymatic activities by molecular docking and circular dichroism spectroscopy. In addition, CQ restored Aβ42‐mediated disruption of GSH homeostasis via regulating YAP1 expression to protect cells against oxidative stress. Our findings not only improve the current understanding of the mechanism of CQ as a potential drug for AD treatment but also provide ideas for subsequent drug research and development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China.
- Qinghai Key Laboratory of Qinghai-Tibet Plateau Biological Resources, Northwest Institute of Plateau Biology, The Chinese Academy of Sciences, Xining, China.
- College of Biological Science and Medical Engineering, Donghua University, Shanghai, China.
Förderung
- Shanghai Natural Science Foundation
- The Open Project of Qinghai Key Laboratory of Qinghai-Tibet Plateau Biological Resources
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Zheng, Q., Zhu, H., Lv, C., Zhu, Z., Cui, H., Fan, Z., Sun, J., Huang, Z., & Shi, P. (2024). Clioquinol rescues yeast cells from Aβ42 toxicity via the inhibition of oxidative damage. Biotechnology Journal. https://doi.org/10.1002/biot.202300662
Vancouver
Zheng Q, Zhu H, Lv C, Zhu Z, Cui H, Fan Z, et al. Clioquinol rescues yeast cells from Aβ42 toxicity via the inhibition of oxidative damage. Biotechnology Journal. 2024. doi:10.1002/biot.202300662
BibTeX
@article{Zheng2024,
author = {Zheng, Qiaoqiao and Zhu, Hongzheng and Lv, Chunyi and Zhu, Ziting and Cui, Hanyue and Fan, Zheyu and Sun, Jing and Huang, Zhiwei and Shi, Ping},
title = {Clioquinol rescues yeast cells from Aβ42 toxicity via the inhibition of oxidative damage},
journal = {Biotechnology Journal},
year = {2024},
doi = {10.1002/biot.202300662}
}
EUVIMED